Key Insights

Highlights

Treatment Research

1 treatments under study, led by Alefacept

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01319851Not ApplicableTerminated

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Showing all 1 trials

Research Network

Common Treatments

  • Alefacept1

Active Sponsors

  • Children's Healthcare of Atlanta1
  • Emory University1

Top Investigators

Related Conditions

  • Chronicgranulomatous Disease1
  • Diamondblackfan Anemia1
  • Fanconi Anemia1
  • Wiskottaldrich Syndrome1
  • Chediakhigashi Syndrome1

Activity Timeline